Covalon Technologies (OTCMKTS:CVALF – Get Free Report) announced its earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.05, Zacks reports. Covalon Technologies had a net margin of 5.05% and a return on equity of 5.77%.
Covalon Technologies Price Performance
CVALF opened at $1.66 on Thursday. The business’s 50-day moving average price is $1.57 and its two-hundred day moving average price is $1.45. Covalon Technologies has a 1 year low of $1.16 and a 1 year high of $1.74. The company has a market capitalization of $45.71 million, a price-to-earnings ratio of 41.39 and a beta of 0.59.
Covalon Technologies Company Profile
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
Featured Articles
- Five stocks we like better than Covalon Technologies
- J.M. Smucker’s Rally Nears a Key Test: Is a Full Recovery Ahead?
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
